# Mirati Therapeutics Inc. (MRTX)

Source: https://www.quantisnow.com/company/MRTX
Generated: 2026-11-19T05:42:30.853Z

- Ticker: MRTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: mirati.com

## About

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

## Latest MRTX news and filings

- 2024-02-14 21:21 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-mirati-therapeutics-inc-5263724)
- 2024-02-14 19:51 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5262178)
- 2024-02-14 14:13 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5260017)
- 2024-02-14 12:12 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5259299)
- 2024-02-13 22:09 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5256968)
- 2024-02-09 17:29 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5245621)
- 2024-02-09 17:20 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-mirati-therapeutics-inc-5245591)
- 2024-02-08 15:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-mirati-therapeutics-inc-amendment-5240382)
- 2024-02-02 21:05 UTC [SEC Form 15-12G filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-mirati-therapeutics-inc-5226547)
- 2024-01-31 19:08 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-mirati-therapeutics-inc-5219981)
- 2024-01-25 21:32 UTC [SEC Form 4] [Boxer Capital, Llc returned 6,859,544 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/boxer-capital-llc-returned-6859544-shares-to-the-company-sec-5208562)
- 2024-01-25 21:31 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Mirati Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-mirati-therapeutics-inc-amendment-5208541)
- 2024-01-25 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-mirati-therapeutics-inc-5206023)
- 2024-01-25 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-mirati-therapeutics-inc-5206015)
- 2024-01-25 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-mirati-therapeutics-inc-5206008)
- 2024-01-24 01:38 UTC [SEC Form 4] [Cherrington Julie M returned 11,252 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/cherrington-julie-m-returned-11252-shares-to-the-company-closing-5202655)
- 2024-01-24 01:38 UTC [SEC Form 4] [Sharp Shalini returned 16,222 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/sharp-shalini-returned-16222-shares-to-the-company-closing-all-5202654)
- 2024-01-24 01:38 UTC [SEC Form 4] [Davis Aaron I. returned 54,325 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/davis-aaron-i-returned-54325-shares-to-the-company-closing-5202653)
- 2024-01-24 01:37 UTC [SEC Form 4] [Hasnain Faheem returned 24,752 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/hasnain-faheem-returned-24752-shares-to-the-company-closing-all-5202652)
- 2024-01-24 01:37 UTC [SEC Form 4] [Ondrey Aaron returned 39,461 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/ondrey-aaron-returned-39461-shares-to-the-company-closing-all-5202651)
- 2024-01-24 01:37 UTC [SEC Form 4] [Carter Bruce L A returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/carter-bruce-l-a-returned-17273-shares-to-the-company-5202649)
- 2024-01-24 01:37 UTC [SEC Form 4] [Johnson Craig A returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/johnson-craig-a-returned-17273-shares-to-the-company-closing-5202648)
- 2024-01-24 01:37 UTC [SEC Form 4] [Moriarty John B returned 72,335 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/moriarty-john-b-returned-72335-shares-to-the-company-closing-5202647)
- 2024-01-24 01:37 UTC [SEC Form 4] [Hickey Benjamin returned 117,028 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/hickey-benjamin-returned-117028-shares-to-the-company-closing-all-5202646)
- 2024-01-24 01:37 UTC [SEC Form 4] [Martinez Maria E returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/martinez-maria-e-returned-17273-shares-to-the-company-closing-5202645)
- 2024-01-24 01:37 UTC [SEC Form 4] [Sandler Alan B. returned 79,865 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/sandler-alan-b-returned-79865-shares-to-the-company-closing-5202644)
- 2024-01-24 01:37 UTC [SEC Form 4] [Baum Charles M returned 237,871 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/baum-charles-m-returned-237871-shares-to-the-company-closing-5202643)
- 2024-01-24 01:37 UTC [SEC Form 4] [Christensen Jamie returned 154,996 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/christensen-jamie-returned-154996-shares-to-the-company-closing-all-5202642)
- 2024-01-24 01:37 UTC [SEC Form 4] [Gallagher Carol Giltner returned 14,363 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/gallagher-carol-giltner-returned-14363-shares-to-the-company-closing-5202641)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200715)
- 2024-01-23 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200714)
- 2024-01-23 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200713)
- 2024-01-23 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200712)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200711)
- 2024-01-23 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200709)
- 2024-01-23 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200708)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200707)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200706)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200705)
- 2024-01-23 14:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Mirati Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-mirati-therapeutics-inc-5200704)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MRTX
- Earnings history: https://www.quantisnow.com/earnings/MRTX
- Dividend history: https://www.quantisnow.com/dividends/MRTX
- Insider transactions: https://www.quantisnow.com/insiders/MRTX
- Options chain: https://www.quantisnow.com/options/MRTX
- SEC 8-K filings only: https://www.quantisnow.com/company/MRTX/8-k
- RSS and alerts for MRTX: https://www.quantisnow.com/docs/rss-feeds.md
